Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

patient expectations

- PMLiVE

Novartis joins biosimilar Humira push in US

Pharma giant hopes its candidate will follow in the footsteps of Amgen’s Amjevita and BI’s Cyltezo

Shire wins FDA approval for haemophilia dosing software

The web-based myPKFiT supports the pharma firm's Advate treatment

- PMLiVE

UK biotech Vaccitech raises £20m for universal flu shot

Aims to develop a vaccine targeting proteins in the core of the virus

International digital pharma marketing: 10 common problems

Your digital marketing challenges are probably shared by peers in other departments and companies. The good news is that such problems often have simple solutions, or can be avoided completely...

Anthill Agency

Leading NHS suppliers highlighted in shortlist for new HSJ awards

The finalists for the first HSJ Healthcare Partnership Awards have been announced. The awards serve to recognise and celebrate those suppliers who work in partnerships with the NHS to drive...

Wilmington Healthcare

- PMLiVE

Shire claims EU approval for haemophilia A drug Adynovi

The drug will battle Bayer’s Kovaltry and Sobi's Elocta in a bid to capture market share

- PMLiVE

AZ and Merck & Co get FDA breast cancer nod for Lynparza

It becomes the first PARP inhibitor to be approved outside ovarian cancer

Lilly bolsters its oncology team

Kimberly Blackwell is appointed VP early phase development, immuno-oncology

Antabio bolsters leadership team

The French biopharma appoints four new executives

- PMLiVE

The power of pharma businesses to drive social change

The importance of CSR programmes

Through the Looking Glass

Non-traditional innovation

- PMLiVE

How to measure marketing success: profit vs ROI

Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and...

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links